| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 230.084 | 172.228 | 420.655 | 363.455 |
| Total Income - EUR | - | - | - | - | - | - | 230.084 | 172.491 | 421.081 | 363.611 |
| Total Expenses - EUR | - | - | - | - | - | - | 4.280 | 5.095 | 15.105 | 21.981 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 225.804 | 167.396 | 405.975 | 341.630 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 220.414 | 165.909 | 402.596 | 330.052 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Opsis Research S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | 230.239 | 217.188 | 403.489 | 479.824 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 230.084 | 210.451 | 370.804 | 323.826 |
| Cash | - | - | - | - | - | - | 156 | 6.738 | 32.685 | 155.997 |
| Shareholders Funds | - | - | - | - | - | - | 220.454 | 209.059 | 357.622 | 279.450 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 9.785 | 8.130 | 45.948 | 151.704 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 48.670 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7210 - 7210" | |||||||||
| CAEN Financial Year |
7211
|
|||||||||
Comments - Opsis Research S.r.l.